The FDA is involved in regulating drug approvals for GLP-1 Receptor Agonists.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• New York University →

  private university in New York City

  • A gathering involving Jon Batiste and New York University took place on September 1st for the launch of a global collection during the UN General Assembly.Mon 00:21
  • Barron Trump is a student at New York University, while his family's business interests are tied to the Mar-a-Lago Club in Palm Beach.Fri 09:14

Related events

• Eli Lilly referred entities to the FDA regarding the GLP-1 market on August 24, 2026.Aug 26
• Eli Lilly and Company received full FDA approval, expanded a safety study into India, and broke ground on a new facility in Houston while competing in the GLP-1 market.Wed 22:45
• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7
• Eli Lilly warns the FDA about black market drug sales, while U.S. Customs and Border Protection intercepts shipments of illicit GLP-1 drugs.Aug 12
• A product, NitroMist®, requires FDA approval for sale, and distributor access is being established for federal supply channels.Tue 18:01